IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

MYGEN PHARMA LLP

LLPIN : ACP-2885|ROC: RoC-MumbaiActive
Last Updated On : 19-09-2025
LLPINACP-2885
LLP NameMYGEN PHARMA LLP
Number of Partners3
Number of Designated Partners3
ROC CodeRoC-Mumbai
Date of Incorporation20-06-2025
Registered AddressF 1501 Yarrow Nahar Amrit Shakti Chandivali Andheri Mumbai Mumbai Mumbai Maharashtra India 400072
Email IDalok_mahajan1@rediffmail.com
Total Obligation of Contribution1,00,000
Main division of business activity to be carried out in India21
Description of main divisionMANUFACTURE OF PHARMACEUTICALS, MEDICINAL CHEMICAL AND BOTANICAL PRODUCTS
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
07921183SUYASH AGARWAL20-06-2025
11163224BHOOPENDRA KUMAR SARASWAT20-06-2025
11163225NAISHA MAHAJAN20-06-2025
MYGEN PHARMA LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Mumbai, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 20-06-2025 and last updated on 19-09-2025. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, MYGEN PHARMA LLP has a total contribution of INR 1,00,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is F 1501 Yarrow Nahar Amrit Shakti Chandivali Andheri Mumbai Mumbai Mumbai Maharashtra India 400072. Correspondence or inquiries may be sent to the official email address, alok_mahajan1@rediffmail.com.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.